Skip to main content

midazolam maleate (Epistatus®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.

Medicine details

Medicine name midazolam maleate (Epistatus®)
Formulation 2.5mg/0.25ml, 5mg/0.5ml, 7.5mg/0.75ml, 10 mg/1 ml oromucosal solution
Reference number 1445
Indication

Treatment of prolonged, acute, convulsive seizures in adults, adolescents, children and infants aged 3 months and above 

Company Veriton Pharma Limited
BNF chapter Central nervous system
Submission type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 29/07/2024
Follow AWTTC: